Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Key research goals for Alzheimer’s Research UK

Susan Kohlhaas • 2 Mar 2022
ARUK 2022
Alzheimer’s Disease Dementia

Susan Kohlhaas, PhD, Alzheimer’s Research UK, Cambridge, UK, discusses the major research goals of Alzheimer’s Research UK (ARUK) for the next few years. There have been promising developments in translational research in recent years, so the next goal for ARUK is the preparation of clinical researchers to run trials. Another key aim of ARUK is to support early career researchers, and various programs have been implemented to achieve this. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

Disclosures

Susan Kohlhaas is employed by Alzheimer’s Research UK.

More from Susan Kohlhaas

Alzheimer's Research UK future research strategy
1:19
Alzheimer's Research UK future research strategy
Susan Kohlhaas • 2 Mar 2022
Highlights from ARUK 2022
1:50
Highlights from ARUK 2022
Susan Kohlhaas • 2 Mar 2022
How ARUK is working to address major gaps in dementia research
2:26
How ARUK is working to address major gaps in dementia research
Susan Kohlhaas • 2 Mar 2022
How ARUK is challenging gender bias and inequality
2:08
How ARUK is challenging gender bias and inequality
Susan Kohlhaas • 2 Mar 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals